APIC, SHEA react to FDA proposed rule on healthcare antiseptic products

The Association for Professionals in Infection Control and Epidemiology and the Society for Healthcare Epidemiology of America have issued a statement strongly supporting the U.S. Food and Drug Administration’s proposal on healthcare antiseptics.

Advertisement

The FDA proposal requests scientific data supporting that active ingredients used in antiseptics used in healthcare are safe and effective, an idea the APIC and SHEA echo, writing.

“APIC and SHEA strongly agree with FDA’s advice that these products continue to be used consistent with infection control guidelines while additional data is being gathered. Healthcare antiseptics are an important component of infection control strategies in hospitals, clinics, and other healthcare settings, and remain a standard of care to prevent illness and spread of infection.”

To read the full statement, click here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.